TUDORZA Hcp. Find TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) savings card information.
Never miss Tudorzahcp.com updates: Start reading the news feed of TUDORZA Hcp right away! Unfortunately, we cannot detect RSS feed on this website, but you may observe related news or Tudorzahcp.com popular pages instead. It is generally safe for browsing, so you may click any item to proceed to the site.
News, stories and media buzz related to TUDORZA Hcp
-
Theravance Reports Second Quarter 2014 Financial Resultsvia
sauditopbusiness
SOUTH SAN FRANCISCO, CA—(Marketwired – Aug 6, 2014) – Theravance, Inc. ( NASDAQ : THRX ) today reported financial results for the quarter ended June 30, 2014 and announced that its Board of Directors approved a $0.25 per share cash dividend to be paid...
-
FDA Approves BREO(R) ELLIPTA(R) for the Treatment of Adults With Asthma in the USvia
saudiindustrydaily
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA—(Marketwired – Apr 30, 2015) – GlaxoSmithKline plc ( LSE : GSK ) and Theravance, Inc. ( NASDAQ : THRX ) today announced that the US Food and Drug Administration (FDA) has approved BREO® ELLIPTA® (fluticasone...
-
GSK and Theravance Announce Outcome of US FDA Advisory Committee on BREO(R) ELLIPTA(R) in Asthmavia
egyptmarketgateway
LONDON, UNITED KINGDOM and SOUTH SAN FRANCISCO, CA—(Marketwired – Mar 19, 2015) – GlaxoSmithKline plc ( LSE : GSK ) and Theravance, Inc. ( NASDAQ : THRX ) today announced the outcome of the joint meeting of the Pulmonary–Allergy Drugs Advisory Committee...
-
LONDON, UNITED KINGDOM—(Marketwired – Sep 27, 2015) – GlaxoSmithKline plc (GSK) and Theravance, Inc. ( NASDAQ : THRX ) today announced data presented by GSK at the European Respiratory Society (ERS) International Congress (poster PA1001), from an exploratory...
-
BEVESPI AEROSPHERE(TM) Approved by the US FDA for Patients With COPDvia
military-technologies
Demonstrated Superior Improvement in Lung Function Versus Mono-Components and Placebo Only Long Acting Dual Bronchodilator Delivered Through a Pressurized Metered-Dose Inhaler (pMDI) and First Product to Use AstraZeneca's Patented Co-Suspension™ Technology...
You may also like
European Federation of Allergy and Airways Diseases...
We are a European alliance of 45 allergy, asthma and chronic obstructive pulmonary disease (COPD) patients’ associations represent...
Managing Myeloma is an educational initiative dedicated to developing tools, information, and resources that support improved ther...
Tudorzahcp.com popular pages
-
Savings Information | TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) 400 mcg
Find TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder) savings card information.
-
Side Effects | TUDORZA® PRESSAIR® (aclidinium bromide inhalation powder)
Review safety and side effects information for TUDORZA PRESSAIR (aclidinium bromide inhalation powder), a long-term maintenance treatment of bronchospasm associated with COPD.
-
COPD Statistics & Prevalence Information
View COPD statistics and prevalence data for the United States. Data includes prevalence, at-risk groups, primary causes, and common symptoms.
Some worthy website to observe next
Website parameters
-
12 years
Domain age
-
N/A
Visit duration
-
N/A
Daily visitors
-
N/A
Bounce rate
